DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
SHC logo

Sotera Health Company Stock Price

NasdaqGS:SHC Community·US$5.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

SHC Share Price Performance

US$18.73
3.10 (19.83%)
​
US$22.72
Fair Value
US$18.73
3.10 (19.83%)
17.6% undervalued intrinsic discount
US$22.72
Fair Value
Price US$18.73
AnalystConsensusTarget US$22.72
AnalystHighTarget US$25.00
AnalystLowTarget US$18.64
Fri, 21 Aug 26
Fair ValueUS$22.72
Share Pricen/a

SHC Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$22.72 17.6% undervalued intrinsic discount

SHC: Recent Equity Offerings And Lock-Up Expiry Will Shape Market Outlook

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$25 25.1% undervalued intrinsic discount

Bullish View Expects Sterilization Demand And Cobalt 60 Stability To Support Long-Term Upside

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$18.64 Fairly Valued intrinsic discount

Ethylene Oxide Litigation And Regulatory Costs Will Constrain Long Term Prospects

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SHC logo
Sotera Health
17.6% undervalued intrinsic discount

SHC: Recent Equity Offerings And Lock-Up Expiry Will Shape Market Outlook

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 21 Aug
Read Narrative
SHC logo
Sotera Health
25.1% undervalued intrinsic discount

Bullish View Expects Sterilization Demand And Cobalt 60 Stability To Support Long-Term Upside

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 5 Sep
Read Narrative
SHC logo
Sotera Health
Fairly Valued intrinsic discount

Ethylene Oxide Litigation And Regulatory Costs Will Constrain Long Term Prospects

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 7 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystHighTarget
SHC logo

SHC: Higher Margins Will Offset Index Removals And Support Upside Potential

Fair Value: US$25 25.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
SHC logo

SHC: Raised 2026 Outlook And Capacity Expansion Will Drive Future Upside

Fair Value: US$22.72 17.6% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
SHC logo

SHC: Raised Outlook And Margin Assumptions Will Support Steady Future Returns

Fair Value: US$18.64 Fairly Valued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with solid track record.

2 Risks
4 Rewards
View Full Analysis

Sotera Health Company Key Details

US$1.2b

Revenue

US$547.7m

Cost of Revenue

US$668.5m

Gross Profit

US$505.0m

Other Expenses

US$163.5m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.57
54.97%
13.44%
321.4%
View Full Analysis

About SHC

Founded
2015
Employees
3000
CEO
Alton Shader
WebsiteView website
soterahealth.com

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Recent SHC News & Updates

Seeking Alpha • 6h

Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers

Summary Sotera Health Company is rated Buy, leveraging a vertically integrated model and strong MOAT in global medical equipment sterilization. SHC benefits from high customer switching costs, multi-year contracts with major healthcare firms, and robust pricing power in mission-critical services. Q2 2026 results exceeded expectations, prompting raised full-year guidance; SHC trades at a discount to peers on forward EV/EBITDA despite superior margins. Litigation risk from ethylene oxide lawsuits remains the primary threat, but improving leverage and strong free cash flow support the long-term investment case. Read the full article on Seeking Alpha
User avatar
Narrative Update • Sep 05

SHC: Higher Margins Will Offset Index Removals And Support Upside Potential

Analysts have nudged their price target on Sotera Health from $24.00 to $25.00, citing updated assumptions that combine a slightly higher discount rate and softer revenue growth expectations with a higher projected profit margin and a lower future P/E multiple. What's in the News for Sotera Health Sotera Health was dropped from the Russell 2500 Growth Benchmark, according to index constituent changes.

Recent updates

No updates

Sotera Health Company Competitors

WAT logo

Waters

Symbol: NYSE:WAT
Market cap: US$42.2b
RVMD logo

Revolution Medicines

Symbol: NasdaqGS:RVMD
Market cap: US$42.2b
ONC logo

BeOne Medicines

Symbol: NasdaqGS:ONC
Market cap: US$40.2b
ILMN logo

Illumina

Symbol: NasdaqGS:ILMN
Market cap: US$37.0b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide